The size of the pharmaceutical packaging market in USA will reach up to USD 28.3 billion by 2025 and would expand up to USD 35.2 billion for the market by 2035. Sales in the forecast period of 2025 to 2035 are anticipated to grow at a CAGR of 2.2%. Revenue of pharmaceutical packaging business in USA in 2024 has already reached up to USD 27.8 billion.
Bottles are the most common product in the USA pharmaceutical market because they are versatile, easy to use, and relatively affordable. They are best for liquids, tablets, and capsules. Bottles provide excellent protection, convenience, and tamper evidence.
Bottles also offer clear labeling, which is essential for patients' safety and compliance. Therefore, throughout the evaluation period, bottles will capture the majority share of over 27% compared to other types of product in USA pharmaceutical packaging market.
USA Pharmaceutical Packaging Industry Forecast
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 27.8 billion |
| Estimated Size, 2025 | USD 28.3 billion |
| Projected Size, 2035 | USD 35.2 billion |
| Value-based CAGR (2025 to 2035) | 2.2% |
Among the wide array of materials that are utilized in pharmaceutical packaging in USA, plastic is expected to grab more than 52% market share in coming years. Plastic leads the pharmaceutical packaging in the USA market as well due to local factors such as sophisticated manufacturing facilities, extensive plastic resin production, efficient logistics at reduced costs, and increasing demand for sustainable, light weight solutions with all regulatory compliances. It makes plastic the most versatile and favorable material.
Pharmaceutical packaging market growth over the estimated period in the USA shall be beneficial, which, concurrently will further increase the opportunity increment value for approximately USD 7.4 billion and subsequently scale up more 1.3 folds than its value of base years by the year 2035.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
Aging Population in USA Leads to Increased Convenient Pharmaceutical Packaging Solutions
The aged population in the USA is strongly pushing the demand for pharmaceutical packaging. The increase in elderly patients accelerates chronic diseases like diabetes, cardiovascular problems, and cancer, which need uninterrupted medication management. To combat this issue, pharmaceutical packaging has evolved to maturity and catered to the requirements of elderly patients.
That is, easy-to-use, child-resistant, and safety-enhanced packaging becomes essential for medication adherence. These blister packs are now in more favor as dispensing one dose is easy, chances of errors reduced, and patient compliance increased.
The self-administered injectable drugs are becoming more in use because they allow for easier pre-filled syringes usage. Such packaging solutions answer the demands of older patients regarding ease, safety, and efficiency in the management of their health.
Rise in Cases of Counterfeit Drugs Drive Demand for Safe Pharmaceutical Packaging
Counterfeit drugs remain a significant problem for the USA, and due to this, packaging regulations have had to be pretty strict. Under the FDA's Drug Supply Chain Security Act, drugs are serialised, such that every pack has a unique identifier, whereby traceability from the supply chain becomes possible.
Tamper-evident packaging along with anti-counterfeit technologies including holograms, QR codes, and RFID chips thus become necessary tools in proving the genuineness of drugs. The same technologies improve tracking and verification to avoid adulteration reaching the consumer. Furthermore, with a state-by-state law and an increasing level of consumer awareness, it is being ensured that pharmaceutical companies in the USA are compelled to introduce such security features.
The future growth in demand for an effective track-and-trace system that could help combat the drug counterfeit business is another significant driver for the demand for advanced pharmaceutical packaging in USA.
Fluctuations in Raw Material Price May Impact Pharmaceutical Packaging Market in USA
The USA pharmaceutical packaging market is challenged since most of its raw materials are imported: plastics, glass, and metals. Then, these raw materials are vulnerable to the vagaries of global pricing, which depend on several factors such as disruptions in supply chains, geopolitical tensions, and fluctuations in demand from other industries.
For example, there have been persistent supply chain bottlenecks, especially post-COVID-19 times, which lead to higher costs of materials of polyethylene and polypropylene, which are in high demand when packaging drugs. These increased costs are then forwarded to pharmaceuticals in the United States, be it absorbed, or passed forward to the customer, thereby being a cost-cutting measure into profit margins or medication prices.
The USA pharmaceutical packaging market experienced a CAGR of 1.7% for the historical period 2020 to 2024. The growth in the USA market for pharmaceutical packaging was positive since the value in 2024 reached USD 27.8 billion compared to USD 26.0 billion in 2020.
USA pharmaceutical packaging sales remain steady as a result of growth in demand for COVID-19 vaccines, high-value biologics, advanced packaging solutions, child-resistant and tamper-evident packaging, pressure from regulatory action, and security issues.
The demand is expected to soar in the coming years with growing demands of an aging population and willingness towards more personalized medicine and biologics. Sustainability and eco-friendly packaging is a greater driver due to the increasing demand for greener solutions with the support of technology integrated as seen with smart packaging enhancing product safety and efficiency.
Tier 1 companies comprise market leaders capturing significant market share in global market. These market leaders are characterized by high production capacity and a wide product portfolio. These market leaders are distinguished by their extensive expertise in manufacturing across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base.
They provide a wide range of series including recycling and manufacturing utilizing the latest technology and meeting the regulatory standards providing the highest quality. Prominent companies within tier 1 include West Pharmaceutical Services, Inc., Amcor plc, J. Penner Corporation, and Aphena Pharma Solutions among others.
Tier 2 companies include mid-size players having presence in specific regions and highly influencing the local market. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Berry Global Group, Inc., Catalent, Inc., Oliver Healthcare Packaging, Indepak, Inc., VisiPak, and Dordan Manufacturing Company.
Tier 3 includes the majority of small-scale companies operating at the local presence and serving niche markets. These companies are notably oriented towards fulfilling local market demands and are consequently classified within the tier 3 share segment.
They are small-scale players and have limited geographical reach. Tier 3, within this context, is recognized as an unorganized market, denoting a sector characterized by a lack of extensive structure and formalization when compared to organized competitors.
The section contains information about the leading segments in the industry. In terms of product types, bottles are estimated to account for a share over 27% by 2035. By drug delivery, oral drugs are projected to dominate by holding a share of 40.3% by the end 2035.
| Product Type | Market Share (2035) |
|---|---|
| Bottles | 27.6% |
Bottles are used in the USA pharmaceutical packaging industry primarily because of their versatility and cost-effectiveness for solid as well as liquid drugs. Robust bottle design ensures durability through transportation and storage, which the USA demands over its long chain of supply.
Child-resistant closure requirements, however very stringent in the USA, also can be complied with by various bottle designs. Bottles further support clear detailed labeling required in FDA guidelines. High demand due to wide over-the-counter prescription use of bottles in the USA, usually prepackaged in bottles for direct consumer usage; advanced manufacturing infrastructure in the USA ensures high volume, low-cost bottles.
| Drug Delivery | Market Share (2035) |
|---|---|
| Oral | 40.3% |
Pharmaceutical packaging is mainly used for oral drugs in the USA due to the huge consumption of over-the-counter (OTC) and prescription medications in tablet, capsule, or liquid form. Oral medications are favored for their convenience and ease of use, which accounts for the preponderance of packaging types like blister packs, bottles, and jars.
The aged demographic in the USA, as well as the emergence of chronic disease conditions, accelerates the increasing need for orally administrable drugs. As a for instance, products from Johnson & Johnson are already marketed using child-resistant bottles by virtue of an FDA ruling pertaining to their blockbuster brand Tylenol.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
Key players of USA pharmaceutical packaging industry are developing and launching new products in the market. They are integrating with different firms and extending their geographical presence. Few of them are also collaborating and partnering with local brands and start-up companies for new product development.
Key Developments in USA Pharmaceutical Packaging Market
Various product types in pharmaceutical packaging include bottles, vials & ampoules, blister, bags & pouches, prefilled syringes and cartridges, sachets, trays, tubes, and containers, jars, and others.
In terms of material, the market of pharmaceutical packaging is divided into plastic, paper, metal and glass. Plastic further include polyethylene, polypropylene, polyvinyl chloride, Polyethylene terephthalate, polystyrene and others. Polyethylene is sub-segmented into HDPE and LDPE.
In terms of drug delivery, the market for pharmaceutical packaging is segmented into ophthalmic, injectable, IV drugs, nasal, wound care, pulmonary, oral, and others (topical and transdermal treatments)
Key sub-regions such as Northeast, Southeast, Southwest, West and Midwest are included.
The USA pharmaceutical packaging industry is projected to witness CAGR of 2.2% between 2025 and 2035.
The USA pharmaceutical packaging industry stood at USD 27.8 billion in 2024.
USA pharmaceutical packaging industry is anticipated to reach USD 35.2 billion by 2035 end.
Northeast is set to record a CAGR of 4.2% in assessment period.
The key players operating in the USA pharmaceutical packaging industry are include West Pharmaceutical Services, Inc., Amcor plc, J. Penner Corporation, and Aphena Pharma Solutions among others.
Explore Healthcare Packaging Insights
View Reports
USA Pharmaceutical Packaging Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
